SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-039652
Filing Date
2019-07-01
Accepted
2019-07-01 15:36:36
Documents
1
Period of Report
2019-06-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4208
  Complete submission text file 0001209191-19-039652.txt   5597
Mailing Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744
Business Address 8201 E. RIVERSIDE DRIVE BUILDING 4, SUITE 100 AUSTIN TX 78744 512-386-2930
XBiotech Inc. (Issuer) CIK: 0001626878 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 77 KING STREET WEST SUITE 3000 TORONTO A6 M5K 1G8
Business Address
Waldin Jan-Paul (Reporting) CIK: 0001733176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37347 | Film No.: 19933035